30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Burkhart Erin

Track

Insider profile

Burkhart Erin's trades of Biomarin Pharmaceutical Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-20 2025-05-20
PrS Proposed sale
41,361
168.54
US$1,260,006 		41,361 168.54 US$1,260,006
2025-05-20 2025-05-20
PlS Planned sale
78,598 -20.0%
75.62
US$381,875 		78,598 -20.0% 75.62 US$381,875
2025-03-20 2025-03-19
PlS Planned sale
37,667 +18.2%
403.46
US$3,743,055 		37,667 +18.2% 403.46 US$3,743,055
2025-03-19 2025-03-19
PrS Proposed sale
1,295
71.52
US$92,618 		1,295 71.52 US$92,618
2025-02-25 2025-02-24
PlS Planned sale
1,344 -9.3%
68.38
US$91,903 		1,344 -9.3% 68.38 US$91,903
2025-02-24 2025-02-24
PrS Proposed sale
1,344
68.38
US$91,903 		1,344 68.38 US$91,903
2024-08-15 2024-08-13
PlS Planned sale
714 -4.7%
90.00
US$64,260 		714 -4.7% 90.00 US$64,260
2024-08-13 2024-08-13
PrS Proposed sale
714
90.00
US$64,260 		714 90.00 US$64,260
2024-04-12 2024-04-10
PlS Planned sale
2,286 -12.4%
90.00
US$205,740 		2,286 -12.4% 90.00 US$205,740
2024-04-10 2024-04-10
PrS Proposed sale
2,286
90.00
US$205,740 		2,286 90.00 US$205,740